ImageneBio, Inc. (IMA) Form S-3 — Aug 5, 2026
ImageneBio filed a Form S-3 shelf registration statement covering the resale of up to 5,770,335 shares of common stock issuable upon exercise of pre-funded warrants held by selling stockholders from a private placement that closed on April 14, 2026. The company is not selling any shares and will receive no proceeds from the resales. The registered share count is large relative to the company's size: 5,770,335 shares compare with 11,279,130 shares outstanding as of July 15, 2026, implying an overhang of roughly half the current share base.
Key figures
- Gross Proceeds
- $30.0 million aggregate purchase price paid by selling stockholders in the April 14, 2026 private placement; company receives no proceeds from this resale
- Offering Price
- $5.199 per pre-funded warrant (April 2026 private placement price); $0.001 per share warrant exercise price
- Shares Offered
- 5770335
- Shares Outstanding
- 11279130
- Nasdaq Symbol
- IMA
- Last Reported Sale Price
- $5.71 (August 4, 2026)
- Beneficial Ownership Limit
- 19.99%
- Estimated Total Registration Expenses
- 56939
- Resale Shares Pct Of Shares Outstanding
- ~51.2%
Price after filing
Close on the filing date to close N calendar days later (from $5.71). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.